Eumycetoma

Clinics in Dermatology

Volumn 30, Issue 4, 2012, Pages 389-396

  Estrada, Roberto ^a   Chávez López, Guadalupe ^a   Estrada Chávez, Guadalupe ^a   López Martínez, Rubén ^b   Welsh, Oliverio ^c  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMPHOTERICIN B; ANTACID AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CISAPRIDE; CLOTRIMAZOLE; CYCLOSPORIN; DIGOXIN; GRISEOFULVIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MEVINOLIN; MIDAZOLAM; NIFEDIPINE; PHENYTOIN; POSACONAZOLE; RIFAMPICIN; RITONAVIR; SIMVASTATIN; SULFONYLUREA; TACROLIMUS; TERBINAFINE; TRIAZOLAM; UNINDEXED DRUG; VORICONAZOLE; WARFARIN;

ABDOMINAL PAIN; ACREMONIUM; ACREMONIUM FALCIFORME; ACREMONIUM KILIENSE; ACREMONIUM RECIFEI; ARTICLE; CURVULARIA; CURVULARIA GENICULATA; DIARRHEA; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHOGRAPHY; EUMYCETOMA; EXOPHIALA; EXOPHIALA JEANSELMEI; FEVER; FUNGUS CULTURE; FUNGUS HYPHAE; FUNGUS IDENTIFICATION; GYNECOMASTIA; HISTOLOGY; HUMAN; HYPERPIGMENTATION; LEG; LEPTOSPHAERIA SENEGALENSIS; LEUKOPENIA; LIBIDO DISORDER; LIP DISEASE; LIVER FUNCTION TEST; LIVER TOXICITY; LOW DRUG DOSE; MADURELLA GRISEA; MADURELLA MYCETOMATIS; MICROSCOPY; MOLECULAR DIAGNOSIS; MYCETOMA; NAUSEA; NEOTESTUDINA ROSATII; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RHABDOMYOLYSIS; SCEDOSPORIUM APIOSPERMUM; SIDE EFFECT; SKIN BIOPSY; UNSPECIFIED SIDE EFFECT; VISUAL DISORDER; VOMITING;

ANTIFUNGAL AGENTS; DRUG RESISTANCE, MULTIPLE, FUNGAL; HUMANS; MYCETOMA;

EID: 84862016834     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.09.009     Document Type: Article

References (70)

1. Finlay G.H., Vismer H.F. Black grain mycetoma. Br J Dermatol 1974, 91:297-303.
2. Buot G., Lavalle P., Mariat F., et al. Etude epidemiologique des mycetomas au mexique a propos de 502 cas. Bull Soc Pathol Exot Filiales 1987, 80:329-339.
3. Wethered D.B., Markey M.A., Hay R.J., et al. Ultraestructural and immunogenic changes in the formation of mycetoma grains. J Med Vet Mycolog 1986, 25:39-46.
4. Morrone A., Hercogová J., Lotti T. Deep mycoses. Dermatology of human mobile population 2004, 188-189. MNL Casa Editrice, Bologna.
5. El Muttardi N., Kulendren D., Jemec B. Madura foot-mind the soil. J Plast Reconstr Aesthet Surg 2010, 63:e576-e578.
6. Lupi O., Tyring S.K., McGinnis M.R. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol 2005, 53:931-951.
7. Maiti P.K., Ray A., Bandyopadhyay S. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health 2002, 7:788-792.
8. Fahal A.H. Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg 2004, 98:3-11.
9. Fahal A.H., Sabaa A.H. Mycetoma in children in Sudan. Trans R Soc Trop Med Hyg 2010, 104:117-121.
10. Hernandez-Hernandez F., Lopez-Marti{dotless}nez R., Mendez-Tovar L.J., Manzano-Gayoso P. Nocardia brasiliensis: in vitro and in vivo growth response to steroid sex hormones. Mycopathologia 1995, 132:79-85.
11. Mendez-Tovar L.J., de Bievre C., Lopez-Marti{dotless}nez R. Effets des hormones sexuelles humaines sur le development in vitro des agents d'eumycetomes. J Mycol Med 1991, 118:141-143.
12. Daoud M., Ezzine Sebai N., Badri T., Mokhtar I., Fazza B., Kamoun M.R. Mycetoma: retrospective study of 13 cases in Tunisia. Acta Dermatovenerol Alp Panonica Adriat 2005, 14:153-156.
13. Elad D., Blum S., Kol A., Ederi N., David D. Eumycetoma caused by Madurella mycetomatis in a mare. Med Mycol 2010, 48:639-642.
14. Brownell I., Pomeranz M., Ma L. Eumycetoma. Dermatol Online J 2005, 11:10.
15. Bonifaz A. Micología médica básica 2010, McGraw Hill, México.
16. Campos P., Bustamante B. Eumycetoma. UpToDate, Inc [Internet]. Available at:, Accessed Nov 30, 2010. http://www.uptodate.com/patients/content/topic.do?topicKey=~KWPPrqh3fCp39hW.
17. McGinnis M.R., Padhye A.A. Fungi causing eumycotic mycetoma. Manual of clinical microbiology 2003, 1848-1856. ASM Press, Washington, DC. 7th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen (Eds.).
18. Ahmed A.O., Van Leeuwen W., Fahal A., et al. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 2004, 4:566-574.
19. Chavez G., Arenas R., Pérez A., et al. Micetomas eumicéticos por Madurella mycetomatis. Informe de seis casos. Rev Iberoam Micol 1998, 15:90-93.
20. Venugopal P.V., Venugopal T.V. Treatment of eumycetoma with ketoconazole. Australas J Dermatol 1993, 34:27-29.
21. Yu Am Zhao S., Nie L.Y. Mycetomas in northern Yemen: identification of causative organisms and epidemiologic considerations. Am J Trop Med Hyg 1993, 48:812-817.
22. Rouphael N., Talati N.J., Franco-Pares C. A painful thorn in the foot: a case of eumycetoma. Am J Med Sci 2007, 334:142-144.
23. Segretain G., Mariat F. Research on the presence of agents of mycetoma in the soil and thorny plants of Senegal and Mauritania. Bull Soc Pathol Exot Filiales 1968, 61:194-202.
24. Segretain G. Epidemiology of mycetomas. Ann Soc Belg Med Trop 1972, 52:277-285.
25. Bustamante B., Campos P.E. Eumycetoma. Atlas of fungal infections 2007, 203. Current Medicine, LLC, New York. 2nd ed. C.A. Kauffman (Ed.).
26. Ameen M., Arenas R. Developments in the management of mycetomas. Clin Exp Dermatol 2009, 34:1-7.
27. Maheshwari S., Figueiredo A., Narurkar S., Goel A. Madurella mycetoma-a rare case with cranial extension. World Neurosurg 2010, 73:69-71.
28. Sarva S.T., Manjunath S.K., Baldwin H.S., Robins D.B., Freire A.X. Lung scedosporiosis in human immunodeficiency virus/acquired immunodeficiency syndrome. Am J Med Sci 2010, 339:300-303.
29. Fahal A.H., El Hassan A.M., Abdelalla A.O., Sheik H.E., Mahgoub E.S. Cystic mycetoma: an unusual clinical presentation of Madurella mycetomatis. Trans R Soc Trop Med Hyg 1998, 92:66.
30. Magaña G., Magaña L. Dermatologia 2003, Editorial Médica Panamericana, Mexico.
31. Padhi S., Uppin S.G., Uppin M.S., et al. Mycetoma in South India: retrospective analysis of 13 cases and description of two cases caused by unusual pathogens: Neoscytalidium dimidiatum and Aspergillus flavus. Int J Dermatol 2010, 49:1289-1296.
32. Estrada G., Vega E., Arenas R., et al. Eumycotic mycetoma caused by Madurella mycetomatis successfully treated with antifungals, surgery, and topical negative pressure therapy. Int J Dermatol 2009, 48:401-403.
33. Hay R.J. Deep mycosis and the skin. Fungi and skin diseases 1993, 51-61. Gower Medical Publishing, London.
34. Ahmed A.O., Abugroun E.S. Unexpected high prevalence of secondary bacterial infection in patients with mycetoma. J Clin Microbiol 1998, 36:850-851.
35. Welsh O. Mycetoma. Semin Dermatol 1993, 12:290-295.
36. Salamon M.L., Edmund Lee J.H., Pinney S.J. Madura foot (Madurella mycetoma) presenting as a plantar fibroma: a case report. Foot Ankle Int 2006, 27:212-215.
37. Gabhane S.K., Gangane N. Anshu. Cytodiagnosis of eumycotic mycetoma: a case report. Acta Cytol 2008, 52:354-356.
38. El Hag I.A., Fahal A.H., Gasim E.T. Fine needle aspiration cytology of mycetoma. Acta Cytol 1996, 40:461-464.
39. Hemalata M., Prasad S., Venkatesh K., et al. Cytological diagnosis of actynomicosis and eumycetomas: a report of two cases. Diagn Cytopathol 2010, 38:918-920.
40. Ahmed A., van de Sande W., Verbrugh H., et al. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal. J Clin Microbiol 2003, 41:4537-4541.
41. Desnos-Ollivier M., Bretagne S., Dromer F., et al. Molecular identification of black-grain mycetoma agents. J Clin Microbiol 2006, 44:3517-3523.
42. Mariat F. Sur la distribution géographique et la répartition des agents de mycetomes. Bull Soc Pathol Exot 1963, 56:33-45.
43. Wethered D.B., Markey M.A., Hay R.J., et al. Humoral immune responses in mycetomas due to Madurella mycetomatis: characterization of specific antibodies by ELISA and immunoblotting. Trans Roy Soc Trop Med 1988, 82:918-923.
44. Hay R.J., Collins M.J. An ultrastructural study of pale eumycetoma grains. Clin Exp Dermatol 1983, 8:553-562.
45. Ahmed A.O., Desplaces N., Leonard P., et al. Molecular detection and identification of agents of eumycetoma: detailed report of two cases. J Clin Microbiol 2003, 41:5813-5816.
46. Yera H., Bougnoux M.E., Jeanrot C., et al. Mycetoma of the foot caused by Fusarium solani: identification of the etiological agent by DNA sequencing. J Clin Microbiol 2003, 41:1805-1808.
47. Ahmed A.O., Adelmann D., Fahal A., et al. Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan. J Cin Microbiol 2002, 40:1031-1036.
48. Mostert L., Groenewald J.L., Summerbell R.C., et al. Species of Phaeoacremonium associated with infections in human and environmental reservoirs in infected woody plants. J Clin Microbiol 2005, 43:1752-1767.
49. Ahmed A.O., Mukhtar M.M., Kools-Sijmons M., et al. Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. J Clin Microbiol 1999, 37:3175-3178.
50. Bonifaz A., De Hoog S., McGinnis R., et al. Eumycetoma caused by Cladophyalophora bantiana successfully treated with itraconazole. Med Mycol 2009, 47:111-114.
51. Hemashettar B.M., Siddaramappa B. Munjunathaswamy BS, et al. Phaeoacremonium krajdenii, a cause of white grain eumycetoma. J Clin Microbiol 2006, 44:4619-4622.
52. Dieng M.T., Sy M.H., Diop B.M., et al. Mycetoma: 130 cases. Ann Dermatol Vénéréol 2003, 130:16-19.
53. Borelli D. Pyrenochaeta mackinnonii. Nova species agente de micetoma. Castellania 1976, 4:227-234.
54. Borelli D., Zamora R. Chaetospaeronema larense nova species agente de micetoma-presentacion del tipo. Bol Mensul Soc Venez Dermatol 1973, 6:17-18.
55. Hay R.J., Mahgoub E.S., Leon G., et al. Mycetoma. J Med Vet Mycol (Suppl) 1992, 30:41-49.
56. Welsh O., Vera-Cabrera L., Salinas-Carmona M.C. Mycetoma. Clin Dermatol 2007, 25:195-202.
57. Czechowski J., Nork M., Haas D., et al. MR and other imaging methods in the investigation of mycetomas. Acta Radiol 2001, 42:24-26.
58. Abd El-Bagi M.E., Fahal A.H. Mycetoma revisited. Incidence of various radiographic signs. Saudi Med J 2009, 30:529-533.
59. Fahal A.H., Sheik H.E., Homeida M.M., et al. Ultrasonographic imaging of mycetoma. Br J Surg 1997, 84:1120-1122.
60. Parker L., Singh D., Biz C. The dot-in-circle sign in Madura foot. J Foot Ankle Surg 2009, 48:690.e1-690.e5.
61. Sharif H.S., Clark D.C., Aabed M.Y., et al. Mycetoma: comparison of MR imaging with CT. Radiology 1991, 178:865-870.
62. Mahgoub E.S., Gumaa S.A. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Trans R Soc Trop Med Hyg 1984, 78:376-379.
63. Fahal A.H. Management of mycetoma. Expert Rev Dermatol 2010, 5:87-93.
64. Turiansky G. Eumycetoma (fungal mycetoma). Emedicine.medscape.com Accessed: Dec 14, 2010. http://emedicine.medscape.com/article/1090738-overview.
65. Negroni R., Tobón A., Bustamante B., Shikanai-Yasuda M.A., Patino H., Restrepo A. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop S Paulo 2005, 47:339-346.
66. Konishi M., Yonekawa S., Nakagawa C., et al. Case of Scedosporium apiospermum cutaneous soft tissue infection treated with voriconazole. Kansenshogaku Zasshi 2008, 82:82-85.
67. Greer N.D. Posaconazole (Noxafil): a new triazole antifungal agent. Proc (Bayl Univ Med Cent) 2007, 20:188-196.
68. U.S.Food and Drug Administration Vfend (Voriconazole) drug information. [Internet]: RxList Inc.; 2010 December Accessed: Dec 8, 2010. http://www.rxlist.com/vfend-drug.htm.
69. Ryder N.S. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 1992, 126:2-7.
70. N'diaye B., Dieng M.T., Perez A., et al. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 2006, 45:154-157.